What is interstitial lung fibrosis?

Interstitial lung fibrosis is a form of interstitial lung disease characterized by amplification and scarring of lung tissue. Interstitial pulmonary fibrosis is often diagnosed as an idiopathic condition, which means that it is not known or the apparent cause of its development, non -infectious chronic disorder. Treatment of this form of lung fibrosis generally involves administration of steroid drugs to control symptoms. In these air boards there are capillaries that work to add oxygen to the blood and remove carbon dioxide. In the presence of lung fibrosis, alveoli are irreversibly damaged due to the formation of a scar tissue, which essentially paralyzes the function of alveoli. As a result, the body is unable to repair damage and breathing is more difficult.

There is no known, definitive cause of interstitial pulmonary fibrosis. It was argued that the inhalation of certain toxins and pollutants such as asbestosis or silicosis could contribute to the beginning of this weakening state. Individuals with a history of radiation exposureOzice, tuberculosis or autoimmune diseases may also be exposed to increased risk of symptomatic. Those who have been diagnosed with gastroesophageal reflux disease (GERD) are considered to be an increased risk of lung fibrosis.

The most significant symptom during the early stages of the disease development is impaired blood oxygenation in the lungs. Deprivation of oxygen can cause fatigue, shortness of breath and a general feeling of restlessness. Other symptoms associated with interstitial lung fibrosis include discomfort, unintentional weight loss and persistent cough. Breathing problems that manifest themselves with the disseasemočáte e progress with time. The onset of symptoms may be acute over time or gradually proceed.

There are several diagnostic tests that can be administered to confirm the diagnosis of lung fibrosis. In order to make the correct diagnosis, other health conditions must be excluded,such as asthma and chronic obstructive lung disease (COPD). Once a complete medical history and physical examination are performed, the individual may be handed over to the battery of other tests.

Imaging testing, such as scanning computed tomography with high resolution (HRCT) and chest X -ray, can be done to evaluate the lung status and determine the scope of the scar that may be present. Tests of lung functions can be performed to assess the lung lung functionality, including lung volumes. A sample of lung tissue, known as a biopsy, can also be accepted to further support the diagnosis of lung fibrosis.

There is no drug for interstitial lung fibrosis; Therefore, treatment is focused on alleviating symptoms and slowing the progression of the disease. Individuals can be prescribed corticosteroids such as prednisone to facilitate inflammation and improve lung function. Other immunosuppressive drugs can be used to replenish the use of corticosteroids, although their use can lead to seriousAid side effects, including glaucoma and impaired red blood cell production.

oxygen therapy can be used to alleviate the difficulty of breathing and facilitate complications such as lightness and dizziness caused by oxygen deprivation. Individuals in advanced stages of lung fibrosis, who did not respond well to traditional treatment, can undergo lung transplantation. For lung transplantation, strict qualifications must be met, including the demonstration that a person is willing to follow with postoperative treatments and rehabilitation requirements and demonstrate the necessary patience and understanding while waiting for a donor.

Complications associated with interstitial lung fibrosis include hypoxemia or low oxygen levels in the blood and pulmonary hypertension. Individuals with this condition are also exposed to an increased risk of developing heart and respiratory failure. Risk factors associated with the onset of lung fibrosis include smoking, exposure to environmental and work risks and advanced age. Idiopathic IntersTicial lung fibrosis can be caused by smoking and exposing certain viral infections. Individuals with a family history of lung fibrosis can also be exposed to a higher risk of developing symptoms.